MEDICAL Q&A: Insulin's costly trip from drugmaker to the US patientSarasota Herald-TribuneA recent paper in the Journal of the American Medical Association found that insulin nearly tripled in cost from 2002 to 2013. A lawsuit filed in January accuses insulin companies of price collusion for allegedly raising prices repeatedly and in lockstep.